Leukemia
An Open label, Multi-center asciminib roll-over study to assess long-term safety in patients who have completed a Novartis sponsored Asciminib study and are judged by the Investigator to benefit from continued treatment. Protocol No.: CABL001A2001B
- Details
ClinicalTrials.gov ID:
NCT04877522
Diagnosis Type:
NA
USOR Number:
- Address
,
P: